| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pediatrics, University of Minnesota (J.G.G., K.K.N., J.A.P., J.P.N., A.C.M., L.L.R.), Minneapolis, Minnesota 55455; Department of Radiation Physics, University of Texas M. D. Anderson Cancer Center (M.S.), Houston, Texas 77030; Departments of Radiation Oncology (S.W.) and Pediatrics (C.A.S.), Memorial Sloan-Kettering Cancer Center, New York, New York 10021; and Departments of Neurology and Pediatrics, Childrens National Medical Center, George Washington University (R.J.P.), Washington, D.C. 20010
Address all correspondence and requests for reprints to: Charles A. Sklar, M.D., Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021. E-mail: sklarc{at}mskcc.org.
The objectives of this study were 1) to compare final height and body mass index (BMI) between adult survivors of childhood brain cancer and age- and sex-matched population norms, 2) to quantify the effects of treatment- and cancer-related factors on the risk of final height below the 10th percentile (adult short stature) or having a BMI of 30 kg/m2 or more (obesity). Treatment records were abstracted and surveys completed by 921 adults aged 2045 yr who were treated for brain cancer as children and were participants in the multicenter Childhood Cancer Survivor Study. Nearly 40% of childhood brain cancer survivors were below the 10th percentile for height. The strongest risk factors for adult short stature were young age at diagnosis and radiation treatment involving the hypothalamic-pituitary axis (HPA). The multivariate odds ratio for adult short stature among those 4 yr of age or younger at diagnosis, relative to ages 1020 yr, was 5.67 (95% confidence interval, 3.68.9). HPA radiation exposure increased the risk of adult short stature in a dose-response fashion (trend test, P < 0.0001). Adjuvant chemotherapy was not an independent risk factor for adult short stature. BMI distribution in survivors did not differ appreciably from that of population norms; however, in females, young age at diagnosis and HPA radiation dose (trend test, P < 0.001) were associated with risk of obesity. Except for patients treated with surgery only, survivors of childhood brain cancer are at very high risk for adult short stature, and this risk increases with radiation dose involving the HPA. We did not find a corresponding elevated risk for obesity.
This work was supported by National Cancer Institute Grant U24-CA-55727 and the Childrens Cancer Research Fund at University of Minnesota.
Abbreviations: BMI, Body mass index; CCSS, Childhood Cancer Survivor Study; 95% CI, 95% confidence interval; GHRT, GH replacement therapy; HPA, hypothalamic-pituitary axis; NHIS, National Health Interview Survey; OR, odds ratio; PNET, primitive neuroectodermal tumor/medulloblastoma; SDS, SD score.
This article has been cited by other articles:
![]() |
S. J. Laughton, T. E. Merchant, C. A. Sklar, L. E. Kun, M. Fouladi, A. Broniscer, E. B. Morris, R. P. Sanders, M. J. Krasin, J. Shelso, et al. Endocrine Outcomes for Children With Embryonal Brain Tumors After Risk-Adapted Craniospinal and Conformal Primary-Site Irradiation and High-Dose Chemotherapy With Stem-Cell Rescue on the SJMB-96 Trial J. Clin. Oncol., March 1, 2008; 26(7): 1112 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Armstrong, C. A. Sklar, M. M. Hudson, and L. L. Robison Long-Term Health Status Among Survivors of Childhood Cancer: Does Sex Matter? J. Clin. Oncol., October 1, 2007; 25(28): 4477 - 4489. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Bowers, Y. Liu, W. Leisenring, E. McNeil, M. Stovall, J. G. Gurney, L. L. Robison, R. J. Packer, and K. C. Oeffinger Late-Occurring Stroke Among Long-Term Survivors of Childhood Leukemia and Brain Tumors: A Report From the Childhood Cancer Survivor Study J. Clin. Oncol., November 20, 2006; 24(33): 5277 - 5282. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Maunsell, L. Pogany, M. Barrera, A. K. Shaw, and K. N. Speechley Quality of Life Among Long-Term Adolescent and Adult Survivors of Childhood Cancer J. Clin. Oncol., June 1, 2006; 24(16): 2527 - 2535. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Ness, A. C. Mertens, M. M. Hudson, M. M. Wall, W. M. Leisenring, K. C. Oeffinger, C. A. Sklar, L. L. Robison, and J. G. Gurney Limitations on Physical Performance and Daily Activities among Long-Term Survivors of Childhood Cancer Ann Intern Med, November 1, 2005; 143(9): 639 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lipshultz, S. A. Vlach, S. R. Lipsitz, S. E. Sallan, M. L. Schwartz, and S. D. Colan Cardiac Changes Associated With Growth Hormone Therapy Among Children Treated With Anthracyclines Pediatrics, June 1, 2005; 115(6): 1613 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Greving and S. J. Santacroce Cardiovascular Late Effects Journal of Pediatric Oncology Nursing, January 1, 2005; 22(1): 38 - 47. [Abstract] [PDF] |
||||
![]() |
H K Gleeson and S M Shalet The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours Endocr. Relat. Cancer, December 1, 2004; 11(4): 589 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Brownstein, A. C. Mertens, P. A. Mitby, M. Stovall, J. Qin, G. Heller, L. L. Robison, and C. A. Sklar Factors That Affect Final Height and Change in Height Standard Deviation Scores in Survivors of Childhood Cancer Treated with Growth Hormone: A Report from the Childhood Cancer Survivor Study J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4422 - 4427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ross, K. C. Oeffinger, S. M. Davies, A. C. Mertens, E. K. Langer, W. R. Kiffmeyer, C. A. Sklar, M. Stovall, Y. Yasui, and L. L. Robison Genetic Variation in the Leptin Receptor Gene and Obesity in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study J. Clin. Oncol., September 1, 2004; 22(17): 3558 - 3562. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Oeffinger and M. M. Hudson Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors CA Cancer J Clin, July 1, 2004; 54(4): 208 - 236. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |